(Q39663939)

13 September 2017

title

Novel ZEB1 expression in bladder tumorigenesis (English)

1 reference

13 September 2017

9

Massimo Loda

1 reference

13 September 2017

10

Douglas S. Darling

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20735391

22 June 2024

author name string

Brasil Silva Neto

4

1 reference

13 September 2017

Juan Miguel Mosquera

7

1 reference

13 September 2017

Ron Zeheb

8

1 reference

13 September 2017

Patrick A. Kenney

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20735391

22 June 2024

Matthew F. Wszolek

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20735391

22 June 2024

Kimberly M. Rieger-Christ

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20735391

22 June 2024

Justin J. Gould

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20735391

22 June 2024

Niall J. Harty

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20735391

22 June 2024

John A. Libertino

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20735391

22 June 2024

Ian C. Summerhayes

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20735391

22 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20735391

22 June 2024

publication date

24 August 2010

1 reference

full work available at URL

13 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1464-410X.2010.09489.x

1 reference

https://api.crossref.org/works/10.1111/J.1464-410X.2010.09489.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.2010.09489.x/fullpdf

22 June 2024

1 reference

https://api.crossref.org/works/10.1111/J.1464-410X.2010.09489.X

22 June 2024

1 reference

13 September 2017

volume

107

1 reference

13 September 2017

issue

4

1 reference

13 September 2017

page(s)

656-663

1 reference

Epithelial-mesenchymal transitions in tumour progression

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09489.X

Epithelial-mesenchymal transitions in development and pathologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09489.X

Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09489.X

Molecular requirements for epithelial-mesenchymal transition during tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09489.X

TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09489.X

Leaving the neighborhood: molecular mechanisms involved during epithelial-mesenchymal transition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09489.X

Transforming growth factor-beta signaling during epithelial-mesenchymal transformation: implications for embryogenesis and tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09489.X

Altered localization of p120 catenin during epithelial to mesenchymal transition of colon carcinoma is prognostic for aggressive disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09489.X

Identification and prognostic significance of an epithelial-mesenchymal transition expression profile in human bladder tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09489.X

Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09489.X

The expression of Twist has an impact on survival in human bladder cancer and is influenced by the smoking status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09489.X

TWIST is expressed in human gliomas and promotes invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09489.X

Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09489.X

Twist overexpression correlates with hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09489.X

Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09489.X

The transcription factor ZEB1 is aberrantly expressed in aggressive uterine cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09489.X

ZEB1 expression in type I vs type II endometrial cancers: a marker of aggressive disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09489.X

A transient, EMT-linked loss of basement membranes indicates metastasis and poor survival in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09489.X

The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09489.X

The transcription factor ZEB1 (deltaEF1) represses Plakophilin 3 during human cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09489.X

Plakophilin 3 oncogene as prognostic marker and therapeutic target for lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09489.X

Non-coding RNAs take centre stage in epithelial-to-mesenchymal transition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09489.X

The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09489.X

The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09489.X

A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09489.X

Zeb1 links epithelial-mesenchymal transition and cellular senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09489.X

The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09489.X

Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09489.X

Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09489.X

Bladder cancer outcome and subtype classification by gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09489.X

A MicroRNA expression profile defining the invasive bladder tumor phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09489.X

SIP1 protein protects cells from DNA damage-induced apoptosis and has independent prognostic value in bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09489.X

Amplification and overexpression of E2F3 in human bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09489.X

E2F3 amplification and overexpression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09489.X

A microRNA expression ratio defining the invasive phenotype in bladder tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09489.X

Significance of TWIST expression and its association with E-cadherin in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09489.X

High Twist expression is involved in infiltrative endometrial cancer and affects patient survival

21 January 2018

15

1 reference

https://api.crossref.org/works/10.1111/J.1464-410X.2010.09489.X

The transcriptional repressor ZEB1 promotes metastasis and loss of cell polarity in cancer

22 June 2024

20

1 reference

https://api.crossref.org/works/10.1111/J.1464-410X.2010.09489.X

22 June 2024

Identifiers

1 reference

13 September 2017

1 reference